0
Signin
countryflagUS

18889881171

AAPL 169.89 0.5147% MSFT 399.04 -2.4495% GOOG 157.95 -1.9553% GOOGL 156.0 -1.9669% AMZN 173.67 -1.6535% NVDA 826.32 3.7087% META 441.38 -10.5613% TSLA 170.18 4.9652% TSM 136.58 2.7149% LLY 724.87 -1.0011% V 275.16 0.0509% AVGO 1294.42 2.9917% JPM 193.37 0.1502% UNH 493.86 1.3462% NVO 125.79 -0.2933% WMT 60.21 0.5679% LVMUY 167.91 -2.1618% XOM 121.35 0.2478% LVMHF 837.0 -2.6461% MA 462.11 -0.0843%

Blue Water Vaccines Inc

Healthcare US BWV

NoneUSD
-(-%)

Last update at 2024-04-09T03:57:48.085185Z

Day Range

--
LowHigh

52 Week Range

0.161.95
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -13.41983M -3.41733M -1.59947M -0.82191M
Minority interest - - - -
Net income -13.29026M -3.41733M -1.57686M -0.76360M
Selling general administrative 9.35M 2.09M 1.10M 0.82M
Selling and marketing expenses - - - -
Gross profit - - - -
Reconciled depreciation 0.00675M 0.00489M 0.00306M 0.00057M
Ebit -13.48124M -3.41733M -1.62207M -0.88023M
Ebitda -13.54265M -3.41244M -1.61901M -0.87966M
Depreciation and amortization -0.06141M 0.00489M 0.00306M 0.00057M
Non operating income net other - - - -
Operating income -13.48124M -3.41733M -1.62207M -0.88023M
Other operating expenses 13.48M 3.42M 1.62M 0.88M
Interest expense 0.06M 0.00000M 0.02M 0.06M
Tax provision - - - -
Interest income - 0.00000M 0.02M 0.06M
Net interest income - 0.00000M 0.02M 0.06M
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense -0.12957M - -0.02260M -0.05832M
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M
Total operating expenses 13.48M 3.42M 1.62M 0.88M
Cost of revenue - - - -
Total other income expense net 0.06M - 0.02M 0.06M
Discontinued operations - - - -
Net income from continuing ops -13.41983M -3.41733M -1.59947M -0.82191M
Net income applicable to common shares -13.51619M -4.04472M -2.15939M -1.10188M
Preferred stock and other adjustments - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 26.31M 3.08M 4.81M 6.08M
Intangible assets - - - -
Earning assets - - - -
Other current assets 0.47M 1.14M 0.28M 0.00001M
Total liab 3.92M 1.64M 0.08M 0.08M
Total stockholder equity 22.39M 1.45M 4.73M 6.00M
Deferred long term liab - - - -
Other current liab 2.42M 1.06M - 0.06M
Common stock 0.00016M 0.00003M 0.00003M 0.00003M
Capital stock 0.00016M 0.00004M 0.00004M 0.00004M
Retained earnings -19.37650M -5.95667M -2.53934M -0.93987M
Other liab - - 0.00964M 0.00686M
Good will - - - -
Other assets 0.04M - 0.20M 0.01M
Cash 25.75M 1.93M 4.31M 6.05M
Cash and equivalents - - - -
Total current liabilities 3.92M 1.64M 0.07M 0.08M
Current deferred revenue - - - -
Net debt -25.75266M -1.92847M -4.30882M -6.05075M
Short term debt - - - -
Short long term debt - - - -
Short long term debt total - - - -
Other stockholder equity 41.76M 7.40M 7.27M 6.94M
Property plant equipment 0.01M 0.01M 0.02M 0.00693M
Total current assets 26.26M 3.07M 4.60M 6.06M
Long term investments - - - -
Net tangible assets 22.39M 1.45M 4.73M 6.00M
Short term investments - - - -
Net receivables 0.04M 0.15M 0.00980M 0.00833M
Long term debt - - - -
Inventory - -0.15252M - -
Accounts payable 1.50M 0.58M 0.07M 0.02M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income - - - -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other 0.04M - 0.20M 0.01M
Deferred long term asset charges - - - -
Non current assets total 0.05M 0.01M 0.22M 0.02M
Capital lease obligations - - - -
Long term debt total - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -0.00934M -0.00192M -0.01179M -0.00450M
Change to liabilities 1.09M 0.34M 0.05M 0.02M
Total cashflows from investing activities -0.00934M -0.00192M -0.01179M -0.00450M
Net borrowings - - - -0.05462M
Total cash from financing activities 32.53M -0.33419M -0.33419M 6.88M
Change to operating activities 1.47M 0.99M -0.48238M -0.01710M
Net income -13.41983M -3.41733M -1.59947M -0.82191M
Change in cash 23.82M -2.38035M -1.74193M 6.05M
Begin period cash flow 1.93M 4.31M 6.05M 0.00000M
End period cash flow 25.75M 1.93M 4.31M 6.05M
Total cash from operating activities -8.69886M -2.04424M -1.73014M -0.82513M
Issuance of capital stock 34.87M - 0.00000M 6.93M
Depreciation 0.00675M 0.00489M 0.00306M 0.00057M
Other cashflows from investing activities - - - -
Dividends paid - - - -
Change to inventory - - - -
Change to account receivables -0.02333M -0.11496M -0.03648M -0.00833M
Sale purchase of stock -0.56681M - - -
Other cashflows from financing activities -1.76893M -0.33419M -0.01179M 6.93M
Change to netincome 2.18M 0.15M 0.33M 0.00327M
Capital expenditures 0.00934M 0.00192M 0.01M 0.00450M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital 2.54M 1.21M -0.46857M -0.00705M
Stock based compensation 1.97M 0.13M 0.33M 0.00327M
Other non cash items 0.20M 0.02M - -
Free cash flow -8.70820M -2.04616M -1.74193M -0.82963M

Fundamentals

  • Previous Close -
  • Market Cap3.41M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-14.02517M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-1.08

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
BWV
Blue Water Vaccines Inc		 - -% - - - - 0.35 -0.4936
NVO
Novo Nordisk A/S		 -0.37 0.29% 125.79 41.58 31.15 2.13 32.99 2.11 4.70
NONOF
Novo Nordisk A/S		 -3.3 2.60% 123.50 41.06 31.25 2.08 33.11 2.11 4.70
VRTX
Vertex Pharmaceuticals Inc		 -3.06 0.76% 397.70 30.40 24.75 10.68 6.25 9.52 20.36
CSLLY
CSL Ltd		 0.06 0.07% 90.16 42.45 26.95 7.05 5.80 7.85 26.51

Reports Covered

Stock Research & News

View All

Profile

Blue Water Biotech, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company owns ENTADFI, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia. It is also developing a streptococcus pneumoniae vaccine candidate, which is designed to prevent infectious middle ear infections in children, and prevention of pneumonia in the elderly; and universal flu vaccine that provide protection from all virulent strains in addition to licensing a novel norovirus S&P nanoparticle versatile virus-like particle vaccine platform from Cincinnati Children's to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, and others. The company was formerly known as Blue Water Vaccines, Inc. and changed its name to Blue Water Biotech, Inc. in April 2023. Blue Water Biotech, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.

Blue Water Vaccines Inc

201 East Fifth Street, Cincinnati, OH, United States, 45202

Key Executives

Name Title Year Born
Mr. Joseph Hernandez M.S., MBA CEO, Pres & Exec. Chairman 1973
Ms. Erin Henderson Chief Bus. Officer & Corp. Sec. 1975
Mr. Jon M. Garfield Chief Financial Officer 1964
Dr. Brian Price Ph.D. Head of Technology Strategy NA
Dr. Ronald R. Cobb Ph.D. Head of Science & Discovery NA
Mr. Andrew D. Skibo Ph.D. Global Head of Biologics Operations NA
Mr. Theodore Scott Yoho Head of Bus. Devel. NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).